Abstract Details
|
Laura Sander, MD
(Universitätsspital Basel)
PRESENTER |
Dr. Sander has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Oezguer Yaldizli, MD | Dr. Yaldizli has nothing to disclose. |
| Jens Wuerfel, MD (Hoffmann-LaRoche) | Dr. Wuerfel has received personal compensation for serving as an employee of MIAC AG. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Actelion. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. |
| Ludwig Kappos, MD, FAAN (RC2NB, University Hospital Basel) | Dr. Kappos has nothing to disclose. |
| Cristina Granziera, MD, PhD (Basel University Hospital) | The institution of Prof. Granziera has received research support from Novartis. The institution of Prof. Granziera has received research support from Hoffmann La Roche. The institution of Prof. Granziera has received research support from Genzyme Sanofi. The institution of Prof. Granziera has received research support from Biogen. |
| Claudio Gobbi, MD (Ospedale Regionale Lugano) | Dr. Gobbi has nothing to disclose. |
| Jens Kuhle, MD | Dr. Kuhle has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file |